Terry-Ann Burrell, CFO at Beam Therapeutics Inc. (BEAM), sold 65,810 shares at $107.20 ($7.1M) on 2021-06-28, disclosed to the SEC on 2021-06-30.
Open-market sale of $7.1M BEAM by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.86 | 1,100 | $114K | 1.6% |
| 2 | $104.63 | 1,880 | $197K | 2.8% |
| 3 | $104.63 | 1,880 | $197K | 2.8% |
| 4 | $105.34 | 5,220 | $550K | 7.8% |
| 5 | $105.34 | 5,220 | $550K | 7.8% |
| 6 | $106.13 | 8,907 |
| $945K |
| 13.4% |
| 7 | $106.13 | 8,907 | $945K | 13.4% |
| 8 | $107.20 | 3,290 | $353K | 5.0% |
| 9 | $108.45 | 4,803 | $521K | 7.4% |
| 10 | $108.45 | 4,803 | $521K | 7.4% |
| 11 | $109.41 | 19,800 | $2.2M | 30.7% |
| Total | $107.26 avg | 65,810 | $7.1M | 100% |
| Filing → |
| BEAM | SELL | 2023-04-05 | $276K | — | Filing → |
| BEAM | SELL | 2023-01-30 | $3.3M | — | Filing → |
| BEAM | SELL | 2023-01-25 | $1.8M | — | Filing → |